YOUSIF, ALI MUNAIM
 Distribuzione geografica
Continente #
NA - Nord America 420
EU - Europa 279
AS - Asia 165
AF - Africa 7
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 873
Nazione #
US - Stati Uniti d'America 419
IT - Italia 166
CN - Cina 77
SG - Singapore 64
NL - Olanda 41
IE - Irlanda 25
FI - Finlandia 17
VN - Vietnam 16
DE - Germania 11
CI - Costa d'Avorio 7
GB - Regno Unito 7
SE - Svezia 5
IN - India 3
FR - Francia 2
PL - Polonia 2
TR - Turchia 2
AR - Argentina 1
BD - Bangladesh 1
BG - Bulgaria 1
CA - Canada 1
ES - Italia 1
EU - Europa 1
IR - Iran 1
JP - Giappone 1
MK - Macedonia 1
Totale 873
Città #
Chandler 94
Singapore 52
Amsterdam 40
Napoli 37
Ashburn 31
Naples 24
Beijing 23
Millbury 20
Nanjing 20
Princeton 18
Dong Ket 16
Des Moines 15
Boston 14
Santa Clara 11
Rome 9
Shenyang 7
Nanchang 6
Viterbo 6
Milan 5
Tianjin 5
Acton 3
Lawrence 3
Redwood City 3
Acerra 2
Albenga 2
Cisterna di Latina 2
Dallas 2
Florence 2
Hebei 2
Helsinki 2
Marigliano 2
New York 2
Norwalk 2
Pomezia 2
Salerno 2
Seattle 2
Warsaw 2
Wilmington 2
Woodbridge 2
Amalfi 1
Ann Arbor 1
Aquila 1
Augusta 1
Calvizzano 1
Camerino 1
Caserta 1
Castellana Grotte 1
Changsha 1
Dearborn 1
Deptford 1
Dhaka 1
Dublin 1
Eboli 1
Genoa 1
Guangzhou 1
Hangzhou 1
Kish 1
Kronberg 1
London 1
Marano 1
Montecchio Emilia 1
Mountain View 1
Munich 1
Málaga 1
Ningbo 1
Nürnberg 1
Ottawa 1
Pescopagano 1
Pune 1
Sant'anastasia 1
Sant'arpino 1
Seregno 1
Skopje 1
Sofia 1
Sunnyvale 1
Totale 530
Nome #
Functional Selectivity Revealed by N-Methylation Scanning of Human Urotensin II and Related Peptides 76
Screening Platform toward New Anti-HIV Aptamers Set on Molecular Docking and Fluorescence Quenching Techniques 71
Urokinase receptor derived peptides as potent inhibitors of the formyl peptide receptor type 1-triggered cell migration 63
Cyclization of the urokinase receptor-derived Ser-Arg-Ser-Arg-Tyr peptide generates a potent inhibitor of trans-endothelial migration of monocytes 59
Glycine-replaced derivatives of [Pro3,DLeu9]TL, a temporin L analogue: Evaluation of antimicrobial, cytotoxic and hemolytic activities 53
Urotensin II(4-11) Azasulfuryl Peptides: Synthesis and Biological Activity 52
Discovery of New Potent Ligands at Human Urotensin-II Receptor 51
An investigation into the origin of the biased agonism associated with the urotensin II receptor activation 49
The urokinase receptor-derived cyclic peptide [SRSRY] suppresses neovascularization and intravasation of osteosarcoma and chondrosarcoma cells 43
Boosting Fmoc Solid-Phase Peptide Synthesis by Ultrasonication 41
Discovery of Novel Potent and Selective Agonists at the Melanocortin-3 Receptor 40
Design, synthesis, and conformational analysis of Melanotropin analogues of MTII and SHU9119. 39
Design, Synthesis, and Conformational Analysis of Melanotropin Analogues of MTII and SHU9119 39
Structure-Activity Study of the Peptides P5U and Urantide by the Development of Analogues Containing Uncoded Amino Acids at Position9 39
Urotensin-II-Targeted Liposomes as a New Drug Delivery System towards Prostate and Colon Cancer Cells 37
Treatment with a Urokinase Receptor-derived Cyclized Peptide Improves Experimental Colitis by Preventing Monocyte Recruitment and Macrophage Polarization 34
Urotensin II receptor determines prognosis of bladder cancer regulating cell motility/invasion 33
Development of Macrocyclic Peptidomimetics Containing Constrained α,α-Dialkylated Amino Acids with Potent and Selective Activity at Human Melanocortin Receptors 33
DESIGN AND SYNTHESIS OF N-METHYL DERIVATIVES OF UROTENSIN-II 31
Urotensin-II Ligands: An Overview from Peptide to Nonpeptide Structures 29
Lead Optimization of P5U and Urantide: Discovery of Novel Potent Ligands at the Urotensin-II Receptor 29
Screening Platform toward New Anti-HIV Aptamers Set on Molecular Docking and Fluorescence Quenching Techniques 4
Totale 945
Categoria #
all - tutte 4.047
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.047


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202047 0 0 0 0 6 5 2 2 1 9 21 1
2020/202166 2 1 1 0 5 17 1 9 8 1 2 19
2021/2022134 0 3 1 3 1 3 0 4 27 19 22 51
2022/2023244 21 8 10 10 31 33 0 28 46 41 9 7
2023/2024144 8 27 12 7 15 18 2 21 2 2 23 7
2024/202597 24 45 5 17 6 0 0 0 0 0 0 0
Totale 945